Phase I study of erlotinib (tarceva) and temsirolimus (CCI-779) for patients with recurrent malignant gliomas (NABTC 04-02)
Conference
Wen, PY, Chang, SM, Kuhn, J et al. (2006). Phase I study of erlotinib (tarceva) and temsirolimus (CCI-779) for patients with recurrent malignant gliomas (NABTC 04-02)
. NEURO-ONCOLOGY, 8(4), 454-454.
Wen, PY, Chang, SM, Kuhn, J et al. (2006). Phase I study of erlotinib (tarceva) and temsirolimus (CCI-779) for patients with recurrent malignant gliomas (NABTC 04-02)
. NEURO-ONCOLOGY, 8(4), 454-454.